Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2022-09-30 Purchase |
2022-10-03 7:57 pm |
KEMPHARM INC | KMPH | Clifton R. LaDuane CFO, Secretary & Treasurer |
1,000 | $5.9812 | $5,981 | 8,109 (Direct) |
View |
| 2022-05-25 Purchase |
2022-05-26 8:30 pm |
KEMPHARM INC | KMPH | Tierney David S Director |
2,000 | $4.39 | $8,780 | 5,835 (Direct) |
View |
| 2022-05-25 Purchase |
2022-05-25 9:03 pm |
KEMPHARM INC | KMPH | Mickle Travis C President & CEO |
13,000 | $4.3843 | $56,996 | 171,774 (Indirect Direct) |
View |
| 2022-05-20 Purchase |
2022-05-24 8:58 pm |
KEMPHARM INC | KMPH | SEYMOUR TAMARA A Director |
200 | $4.87 | $974 | 200 (Direct) |
View |
| 2022-05-18 Purchase |
2022-05-18 7:01 pm |
KEMPHARM INC | KMPH | Plooster Matthew R Director |
5,000 | $4.9561 | $24,780 | 9,101 (Indirect Direct) |
View |
| 2022-05-18 Purchase |
2022-05-18 5:25 pm |
KEMPHARM INC | KMPH | Pascoe Richard W Executive Chairman |
5,000 | $4.9215 | $24,608 | 8,285 (Direct) |
View |
| 2022-05-18 Purchase |
2022-05-18 5:17 pm |
KEMPHARM INC | KMPH | Clifton R. LaDuane CFO, Secretary & Treasurer |
1,200 | $4.9992 | $5,999 | 6,440 (Direct) |
View |
| 2021-11-30 Purchase |
2021-11-30 7:42 pm |
KEMPHARM INC | KMPH | Pascoe Richard W Executive Chairman |
1,500 | $7.8814 | $11,822 | 3,285 (Direct) |
View |
| 2021-11-30 Purchase |
2021-11-30 4:10 pm |
KEMPHARM INC | KMPH | Tierney David S Director |
2,000 | $7.789 | $15,578 | 3,835 (Direct) |
View |
| 2021-11-18 Purchase |
2021-11-23 4:03 pm |
KEMPHARM INC | KMPH | Mickle Travis C President & CEO |
2,250 | $8.2295 | $18,516 | 158,774 (Indirect Direct) |
View |
| 2021-11-18 Purchase |
2021-11-18 4:57 pm |
KEMPHARM INC | KMPH | Clifton R. LaDuane CFO, Secretary & Treasurer |
510 | $8.29 | $4,228 | 5,240 (Direct) |
View |
| 2021-09-29 Purchase |
2021-09-29 4:10 pm |
KEMPHARM INC | KMPH | Clifton R. LaDuane CFO, Secretary & Treasurer |
215 | $9.38 | $2,017 | 4,730 (Direct) |
View |
| 2021-09-20 Purchase |
2021-09-20 5:03 pm |
KEMPHARM INC | KMPH | Clifton R. LaDuane CFO, Secretary & Treasurer |
935 | $8.5865 | $8,028 | 4,515 (Direct) |
View |
| 2021-09-01 Purchase |
2021-09-01 4:04 pm |
KEMPHARM INC | KMPH | Clifton R. LaDuane CFO, Secretary & Treasurer |
230 | $9.105 | $2,094 | 3,580 (Direct) |
View |
| 2021-08-30 Purchase |
2021-08-30 5:09 pm |
KEMPHARM INC | KMPH | Mickle Travis C President & CEO |
5,000 | $8.9215 | $44,608 | 156,524 (Indirect Direct) |
View |
| 2021-06-23 Purchase |
2021-06-24 4:22 pm |
KEMPHARM INC | KMPH | Clifton R. LaDuane CFO, Secretary & Treasurer |
75 | $14.11 | $1,058 | 3,350 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2023-01-09 Option Award |
2023-01-11 9:49 pm |
N/A 2033-01-08 |
KEMPHARM INC | KMPH | Schafer Joshua CCO & EVP, Bus. Development |
300,000 | $0 | 300,000 (Direct) |
View |
| 2023-01-09 Option Award |
2023-01-11 9:46 pm |
N/A 2033-01-08 |
KEMPHARM INC | KMPH | Pascoe Richard W Chief Executive Officer |
700,000 | $0 | 700,000 (Direct) |
View |
| 2023-01-09 Option Award |
2023-01-11 9:45 pm |
N/A 2033-01-08 |
KEMPHARM INC | KMPH | Sangiovanni Timothy J. SVP, Corporate Controller |
136,986 | $0 | 136,986 (Direct) |
View |
Ownership |
2023-01-10 9:19 pm |
N/A N/A |
KEMPHARM INC | KMPH | Mickle Christal M M Chief Product Dev. Officer |
0 | $0 | 249,228 (Direct) |
View |
Ownership |
2022-11-30 4:40 pm |
N/A 2032-11-27 |
KEMPHARM INC | KMPH | Posner Christopher Director |
0 | $0 | 22,500 (Direct) |
View |
| 2022-06-28 Option Award |
2022-06-30 5:20 pm |
N/A 2032-06-27 |
KEMPHARM INC | KMPH | Tierney David S Director |
15,000 | $0 | 15,000 (Direct) |
View |
| 2022-06-28 Option Award |
2022-06-30 5:20 pm |
N/A 2032-06-27 |
KEMPHARM INC | KMPH | Saluri Joseph Director |
15,000 | $0 | 15,000 (Direct) |
View |
| 2022-06-28 Option Award |
2022-06-30 5:19 pm |
N/A 2032-06-27 |
KEMPHARM INC | KMPH | Plooster Matthew R Director |
15,000 | $0 | 15,000 (Direct) |
View |
| 2022-06-28 Option Award |
2022-06-30 5:19 pm |
N/A 2032-06-27 |
KEMPHARM INC | KMPH | SEYMOUR TAMARA A Director |
15,000 | $0 | 15,000 (Direct) |
View |
| 2022-02-01 Option Award |
2022-02-03 5:17 pm |
N/A 2032-01-31 |
KEMPHARM INC | KMPH | Sangiovanni Timothy J. VP, Corporate Controller |
50,092 | $0 | 50,092 (Direct) |
View |
| 2022-02-01 Option Award |
2022-02-03 5:17 pm |
N/A 2032-01-31 |
KEMPHARM INC | KMPH | Guenther Sven EVP, Research & Development |
83,486 | $0 | 83,486 (Direct) |
View |
| 2022-02-01 Option Award |
2022-02-03 5:15 pm |
N/A 2032-01-31 |
KEMPHARM INC | KMPH | Clifton R. LaDuane CFO, Secretary & Treasurer |
83,486 | $0 | 83,486 (Direct) |
View |
| 2022-02-01 Option Award |
2022-02-03 5:14 pm |
N/A 2032-01-31 |
KEMPHARM INC | KMPH | Pascoe Richard W Executive Chairman |
127,286 | $0 | 127,286 (Direct) |
View |
| 2022-02-01 Option Award |
2022-02-03 5:12 pm |
N/A 2032-01-31 |
KEMPHARM INC | KMPH | Mickle Travis C President & CEO |
267,156 | $0 | 267,156 (Direct) |
View |
| 2021-12-01 Option Award |
2021-12-01 4:28 pm |
N/A N/A |
KEMPHARM INC | KMPH | Plooster Matthew R Director |
2,500 | $8.44 | 4,101 (Direct) |
View |
| 2021-11-10 Option Award |
2021-11-10 9:26 pm |
N/A 2031-11-09 |
KEMPHARM INC | KMPH | Pascoe Richard W Executive Chairman |
100,000 | $0 | 100,000 (Direct) |
View |
| 2021-08-20 Option Award |
2021-08-24 4:51 pm |
N/A 2031-08-19 |
KEMPHARM INC | KMPH | Mickle Travis C President & CEO |
263,743 | $0 | 509,645 (Direct) |
View |
| 2021-08-24 Other |
2021-08-24 4:51 pm |
N/A N/A |
KEMPHARM INC | KMPH | Mickle Travis C President & CEO |
114,607 | $0 | 509,645 (Direct) |
View |
| 2021-08-20 Option Award |
2021-08-24 4:49 pm |
N/A 2031-08-19 |
KEMPHARM INC | KMPH | Clifton R. LaDuane CFO, Secretary & Treasurer |
82,423 | $0 | 82,423 (Direct) |
View |
| 2021-08-20 Option Award |
2021-08-24 4:27 pm |
N/A 2031-08-19 |
KEMPHARM INC | KMPH | Sangiovanni Timothy J. VP, Corporate Controller |
44,023 | $0 | 44,023 (Direct) |
View |
| 2021-08-20 Option Award |
2021-08-24 4:26 pm |
N/A 2031-08-19 |
KEMPHARM INC | KMPH | Guenther Sven EVP, Research & Development |
81,716 | $0 | 81,716 (Direct) |
View |
Ownership |
2021-08-18 5:38 pm |
N/A 2031-08-17 |
KEMPHARM INC | KMPH | SEYMOUR TAMARA A Director |
0 | $0 | 22,500 (Direct) |
View |
| 2021-06-17 Option Award |
2021-06-21 08:36 am |
N/A 2031-06-16 |
KEMPHARM INC | KMPH | Tierney David S Director |
15,000 | $0 | 15,000 (Direct) |
View |
| 2021-06-17 Option Award |
2021-06-21 08:35 am |
N/A 2031-06-16 |
KEMPHARM INC | KMPH | Saluri Joseph Director |
15,000 | $0 | 15,000 (Direct) |
View |